OncoResponse
OncoResponse is a Seattle-based immunotherapy company mentioned among ARCH portfolio companies and in news articles about cell therapy...
Facts
- HQ
- Seattle
- Sectors
- Biotech, Immunotherapy, Biopharmaceuticals
- Founded
- 2016 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- OncoResponse Inc Seattle business license
- Total raised
- $84M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $13.9M · May 2023 SEC Form D
People
-
Clifford Stocks Founder, Executive Officer, Director
